Key Findings:  Collectively, the pre-treatment with BCP, likely acting as agonist for CB2 and PPAR-alpha receptors, modulates in a beneficial way the ECS activation and the lipoperoxidation, taken as indicative of oxidative stress. Furthermore, results support the evidence that BCP may be used as a dietary supplement to control the physiological response to the hypoperfusion/reperfusion-induced oxidative stress.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Italy
Year of Pub:  2018
Cannabinoids Studied: 
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2, PPAR - Alpha
Dosage: β-caryophyllene (40 mg/per rat in 300 μl of sunflower oil as vehicle) 6 h before surgery
Route of Administration:  Oral (Ingestion)